Radiation boost for glioblastoma
Part of Cancer clinical trials.
This study tests whether giving a higher dose of radiation to the tumor area improves outcomes for people with glioblastoma. It is for those who have had surgery or are planned for radiation, and have some remaining tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be willing to follow the study procedures and provide written consent.
- You must have either a new or recurrent glioblastoma (GBM).
- You must be scheduled to have brain surgery or radiation therapy, and if after surgery, there must be visible tumor remaining.
- Your liver and kidney function must be within acceptable limits, as shown by blood tests.
- You and your partner must agree to use highly effective birth control during the study, if applicable.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
This trial tests a new approach to radiation therapy for newly diagnosed, aggressive brain tumors. It uses an MRI-guided machine (MR-linac) to deliver radiation more precisely, while studying how to make treatment safer and more effective.
This trial is testing an escalated dose of proton beam radiation, along with standard chemotherapy and MRI-guided planning, for newly diagnosed glioblastoma. It aims to see whether the higher radiation dose can improve treatment while staying safe for nearby critical brain structures.
This trial tests whether using advanced MRI scans before radiation therapy can help doctors target the tumor more precisely and possibly improve outcomes for people with glioblastoma. It aims to make radiation treatment more personalized.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.